<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-6TE983EH</identifier><date>2009</date><creator>Kastelic, Zvonka</creator><creator>Umičević, Snežana</creator><relation>documents/doc/6/URN_NBN_SI_doc-6TE983EH_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-6TE983EH_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 78-85</format><identifier identifier_type="COBISSID_HOST">824955</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-6TE983EH</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>Kaj mora medicinska sestra vedeti o sistemskem zdravljenju raka in zdravstveni negi?</source><rights>InC</rights><subject language_type_id="slv">Administration and dosage</subject><subject language_type_id="slv">Adverse effects</subject><subject language_type_id="slv">Antineoplastic agents</subject><subject language_type_id="slv">Antineoplastiki</subject><subject language_type_id="slv">Ekstravazacija diagnostičnih in terapevtskih snovi</subject><subject language_type_id="slv">Extravasation of diagnostic and therapeutic materials</subject><subject language_type_id="slv">Flebitis</subject><subject language_type_id="slv">Infusions, intravenous</subject><subject language_type_id="slv">Infuzije, intravenske</subject><subject language_type_id="slv">Phlebitis</subject><subject language_type_id="slv">Predpisovanje in doziranje</subject><subject language_type_id="slv">Škodljivi učinki</subject><title>Aplikacija in lokalni zapleti sistemske intravenozne terapije</title></Record>